Authors
Christopher Sayed, MD, is dermatologist and professor at the University of North Carolina at Chapel Hill Department of Dermatology.
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
3
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
4
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
5





